- Home
- NCSM vs UNCY Comparison
NCSM vs UNCY Comparison
Compare NCSM & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCSM
- UNCY
- Stock Information
- Founded
- NCSM 2006
- UNCY 2016
- Country
- NCSM United States
- UNCY United States
- Employees
- NCSM N/A
- UNCY N/A
- Industry
- NCSM Oilfield Services/Equipment
- UNCY Biotechnology: Pharmaceutical Preparations
- Sector
- NCSM Energy
- UNCY Health Care
- Exchange
- NCSM Nasdaq
- UNCY Nasdaq
- Market Cap
- NCSM 61.1M
- UNCY 71.8M
- IPO Year
- NCSM 2017
- UNCY 2021
- Fundamental
- Price
- NCSM $31.44
- UNCY $0.55
- Analyst Decision
- NCSM
- UNCY Strong Buy
- Analyst Count
- NCSM 0
- UNCY 3
- Target Price
- NCSM N/A
- UNCY $5.50
- AVG Volume (30 Days)
- NCSM 9.5K
- UNCY 567.3K
- Earning Date
- NCSM 04-30-2025
- UNCY 05-16-2025
- Dividend Yield
- NCSM N/A
- UNCY N/A
- EPS Growth
- NCSM N/A
- UNCY N/A
- EPS
- NCSM 3.27
- UNCY N/A
- Revenue
- NCSM $168,704,000.00
- UNCY N/A
- Revenue This Year
- NCSM $7.03
- UNCY N/A
- Revenue Next Year
- NCSM $5.82
- UNCY $1,502.84
- P/E Ratio
- NCSM $9.66
- UNCY N/A
- Revenue Growth
- NCSM 18.16
- UNCY N/A
- 52 Week Low
- NCSM $15.90
- UNCY $0.20
- 52 Week High
- NCSM $38.95
- UNCY $1.16
- Technical
- Relative Strength Index (RSI)
- NCSM 52.40
- UNCY 39.05
- Support Level
- NCSM $29.15
- UNCY $0.59
- Resistance Level
- NCSM $32.71
- UNCY $0.66
- Average True Range (ATR)
- NCSM 1.84
- UNCY 0.04
- MACD
- NCSM 0.26
- UNCY -0.01
- Stochastic Oscillator
- NCSM 38.99
- UNCY 4.00
About NCSM NCS Multistage Holdings Inc.
NCS Multistage Holdings Inc provides products and support services that facilitate the optimization of oil and natural gas well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's primary offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. Geographically, majority of revenue is generated from United States.
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.